EpiCast Report: Clostridium Difficile Infection (CDI) Epidemiology Forecast to 2024 Now Available at iData Insights EpiCast Report: Clostridium Difficile Infection (CDI) - Epidemiology Forecast to 2024 Summary Clostridium difficile infections (CDI) are primarily transmitted through the fecal-oral route. There are two major sources of CDI: healthcare-associated CDI (HA-CDI) and community-associated CDI (CA-CDI). The typical clinical symptoms of CDI range from watery diarrhea, anorexia, and nausea, to hypoalbuminemia and abdominal tenderness in severe cases. Though suspected in all patients with antibiotic-associated diarrhea, the confirmatory diagnosis of CDI is primarily based on the combination of clinical features exhibited by the patient and the results of various laboratory tests including stool tests, as well as, in certain rare scenarios, endoscopy or radiologic tests. Recurrence and complications of CDI usually pose grave challenges for the treatment and management of this condition and occur in about 20-30% of the patients treated successfully for their first episode. GlobalData epidemiologists predict that the diagnosed incident cases of all-CDI will grow from 686,540 cases in 2014 to 825,021 cases in 2024, at an Annual Growth Rate (AGR) of 2.02% over the 10-year forecast period. Throughout the forecast period, the US will have the highest number of diagnosed incident cases of all-CDI in the 7MM. This report provides an overview of the risk factors, comorbidities, and the global and historical trends for CDI in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of all-CDI segmented by sex and by age (in five-year age groups beginning at 18 years and ending at =85 years). The term all-CDI is defined as any instance of suspected CDI and diarrhea, with stool samples testing positive for toxin A, B, or both (enzyme immunoassay [EIA], cytotoxicity test, or polymerase chain reaction [PCR]) or revealing the presence of toxin-producing C. difficile, and includes both HA-CDI and CA-CDI. The report also provides the 10year epidemiology forecast for the all-CDI cases segmented by epidemiological association into HA-CDI and CA-CDI. Additionally, the report provides a 10-year epidemiological forecast for the recurrent all-CDI cases with a further segmentation by number of recurrences. Scope - The Clostridium difficile infection (CDI) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for CDI in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of all-CDI segmented by sex and by age (in five-year age groups beginning at 18 years and ending at =85 years). - The CDI epidemiology report is written and developed by Masters- and PhD-level epidemiologists. - The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM. Reasons to buy The Clostridium Difficile Infection (CDI) EpiCast series will allow you to - - Develop business strategies by understanding the trends shaping and driving the global CDI market. - Quantify patient populations in the global CDI market to improve product design, pricing, and launch plans. - Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for CDI therapeutics in each of the markets covered. Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-page.php?id=124182/epicastreport-clostridium-difficile-infection-cdi-epidemiology-forecast-to-2024 To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-page.php?id=124182/epicastreport-clostridium-difficile-infection-cdi-epidemiology-forecast-to-2024 Table of Contents 1 Table of Contents 4 1.1 List of Tables 6 1.2 List of Figures 7 2 Introduction 8 2.1 Catalyst 8 2.2 Related Reports 9 2.3 Upcoming Reports 9 3 Epidemiology
1
10 3.1 Disease Background 10 3.2 Risk Factors and Comorbidities 11 3.3 Global Trends 13 3.3.1 7MM: Diagnosed Incidence Rates 15 3.3.2 7MM: Diagnosed Incident Cases by Epidemiological Association 16 3.3.3 7MM: Diagnosed Incident Cases by Recurrences 16 3.4 Forecast Methodology 17 3.4.1 Sources Used 19 3.4.2 Sources Not Used 25 3.4.3 Forecast Assumptions and Methods 28 3.5 Epidemiological Forecast of CDI (2014-2024) 34 3.5.1 Diagnosed Incident Cases of All-CDI 34 3.5.2 Age-Specific Diagnosed Incident Cases of All-CDI 36 3.5.3 Sex-Specific Diagnosed Incident Cases of All-CDI 38 3.5.4 Age-Standardized Diagnosed Incidence Rate of All-CDI 40 3.5.5 Recurrent CDI Cases 42 3.5.6 Diagnosed Incident Cases of All-CDI by Epidemiological Association 43 3.6 Discussion 45 3.6.1 Epidemiological Forecast Insight 45 3.6.2 Limitations of the Analysis 47 3.6.3 Strengths of the Analysis 47 4 Appendix 48 4.1 Bibliography 48 4.2 About the Authors 55 4.2.1 Epidemiologists 55 4.2.2 Reviewers 55 4.2.3 Global Director of Therapy Analysis and Epidemiology 57 4.2.4 Global Head of Healthcare 57 4.3 About GlobalData 58 4.4 About EpiCast 58 4.5 Disclaimer Read More @ http://www.idatainsights.com/reports-landing-page.php?id=124182/epicast-report-clostridium-difficileinfection-cdi-epidemiology-forecast-to-2024 About Us:
2
iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.
Contact Us: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com
About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects.
3